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Background and Objectives: Port wine stain (PWS) is
a congenital vascular malformation of the human skin.
Laser is the treatment of choice for PWS. Laser‐resistant
PWS is one crucial factor accounting for inadequate
treatment outcome, which needs to be fully characterized.
This study aims to quantitatively characterize the
morphology of laser‐resistant PWS blood vessels in the
upper papillary dermis using in vivo reflectance confocal
microscopy (RCM).
Study Design/Materials and Methods: A total of 42
PWS subjects receiving laser treatment from August 2016
through July 2018 were enrolled into this study. Thirty‐three
subjects had facial PWS; nine had extremity PWS. All
subject’s PWS received multiplex 585/1,064 nm laser
treatment. RCM images were taken before and after
treatment. The density, diameter, blood flow, and depth of
PWS blood vessels were analyzed.
Results: We found 44.4% PWS on the extremities (four out
of nine subjects) were laser‐resistant, which was significantly
higher (P < 0.001) when compared with those PWS on the
face (15.2%, 5 out of 33 subjects). The laser‐resistant facial
PWS blood vessels had significantly higher blood flow (1.35 ±
0.26 U vs. 0.89 ± 0.22 U, P < 0.001), larger blood vessel
diameters (109.60 ± 18.24 µm vs. 84.36 ± 24.04 µm, P =
0.033) and were located deeper in the skin (106.01 ± 13.87
µm vs. 87.82 ± 12.57 µm, P < 0.001) in the skin when
compared with laser‐responsive PWS on the face. The
average PWS blood vessel density (17.01 ± 4.63/mm2 vs.
16.61 ± 4.44/mm2, P = 0.857) was not correlated to the laser
resistance.
Conclusions: Laser‐resistant PWS blood vessels had
significantly higher blood flow, larger diameters, and were
located deeper in the skin. RCM can be a valuable tool for
a prognostic evaluation on laser‐resistant lesions before
treatment, thereby providing guidance for tailored laser
treatment protocols, which may improve the therapeutic
outcome. The limitations for this study include relative
small sample size and acquisitions of different blood
vessels before and after 2 months of treatment. Lasers
Surg. Med. © 2019 Wiley Periodicals, Inc.
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INTRODUCTION
Port wine stain (PWS) is a congenital progressive
vascular malformation of human skin, resulting from
differentiation‐impaired endothelial cells (ECs) in dermis
with a progressive dilatation of immature venule‐like
vasculatures [1]. PWS occurs in estimated 3–5 infants per
1,000 live births [2–4].
PWS can exist alone or in association with many other
vascular malformations, such as Sturge‐Weber syndrome,
Parkes‐Weber syndrome, Klippel‐Trenaunay syndrome,
and arteriovenous malformations [5]. PWS initially
appear as flat red macules in childhood; lesions tend to
darken progressively to purple and, by middle age, PWS
often become raised as a result of the development of
vascular nodules, which may spontaneous bleed or
hemorrhage [6,7]. Moreover, PWS is a disease with
potentially devastating and lifelong psychological and
social complications that can greatly impair the quality of
life for afflicted individuals [8–10].
Pulsed dye laser (PDL) irradiation at 585–595 nm is the
treatment of choice for PWS. Yellow light absorption by
hemoglobin converts incoming photo energy to heat thus
inducing blood vessel wall necrosis [11–17]. Unfortu-
nately, complete PWS clearance after PDL treatment
occurs in <10% of patients [18–20]. Therefore, laser‐
resistant PWS blood vessel is a crucial factor accounting
for the inadequate treatment outcomes. However, the
morphological and molecular phenotypes of laser‐resis-
tant blood vessels have not been fully characterized. This
knowledge gap hampers the development of more effective
treatments for laser‐resistant lesions.
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Reflectance confocal microscopy (RCM) is a non‐inva-
sive imaging system that has been used to evaluate
cutaneous pathology with cellular level magnification and
resolution in clinical practice at the bedside [21]. RCM can
record dynamic processes in human skin in situ, such as
the cutaneous microcirculation. Various parameters such
as skin thickness, epidermal cell types and sizes, blood
vessel density, size, shape, and depth can be imaged and
analyzed by RCM [21,22]. These features make RCM a
useful tool to evaluate the in vivo dynamic features of
PWS blood vessels before and after laser treatment.
In this study, we aimed to characterize the general
morphology of laser‐resistant PWS blood vessels using
RCM. Our results showed that laser‐resistant facial PWS
blood vessels had significantly higher blood flow, larger
diameters, and were located deeper in the skin when
compared with laser‐responsive PWS on the face. Our
data also suggested that RCM could be a valuable tool for
a prognostic evaluation on laser‐resistant lesions before
treatment, thereby providing guidance for tailored laser
treatment protocols and improving therapeutic outcome.
MATERIALS AND METHODS
Subjects
The study protocol (#16095) was approved by the ethics
committee of the Third Xiangya Hospital, Central South
University, Changsha, Hunan 410013, China. Forty‐two
subjects (25 women and 17 men) receiving laser treat-
ments from August 2016 through July 2018 were enrolled
into this study. Thirty‐three subjects had facial PWS; nine
subjects had extremity PWS. Signed written consent
forms were obtained from each subject before entrance
into the study. Subjects ranged in age from 1 to 48 years
with an average age of 14.3 years. Exclusion criteria
included pregnant and lactating women; subjects sensi-
tive to light or photosensitizers; subjects with skin
inflammatory lesions from bacterial, fungal, or viral
infections; and subjects with complications such as severe
heart, liver, and kidney disease.
Treatment
All subjects’ PWS received multiplex 585/1,064 nm
laser treatment (Cynosure, Inc, Westford, MA), which
delivered sequential PDL and Nd:YAG wavelengths. The
energy densities were 6.5 and 35 J/cm2 with pulse
durations of 0.5 and 15 ms for the 585 and 1,064 nm
wavelengths, respectively, delivered on a spot size of 7
mm. A cooling device was applied during laser treatment.
The entire PWS was treated with no overlap of individual
spots. Subjects received 4–6 laser treatment sessions with
an interval of 4 weeks between successive procedures. The
rationales for using 585/1,064 for treatment of PWS in
this study are (i) 1,064 nm can target blood vessels suiting
deeply in dermis where the 585 nm cannot reach
effectively and (ii) 585 nm first converts hemoglobin to
methaemoglobin that has an absorption coefficient closely
matching with 1,064 nm, rendering a synergistic effect for
PWS treatment by using dual wavelengths.
RCM Imaging
RCM imaging was performed on the exact same PWS
site from every subject before treatment at baseline and
again 2 months after the final laser treatment using a
VivaScope® 1500 (Caliber Imaging and Diagnostics; Lucid
Inc., Rochester, NY) system. This RCM uses 830 nm light,
which will penetrate to a maximal depth of 250–300 µm
into the human skin with a resolution of <1.25 µm
horizontally and <5.0 µm vertically. The maximal scan-
ning depth of 150 µm used in this study was to ensure the
optimal resolution of PWS blood vessels in the papillary
dermis. The scanning depth was pre‐set at 100 µm in the
upper papillary dermis. The scanning was then increased
stepwise at 3.05 µm up or down for several layers from the
initial depth of 100 µm. Two to three layers with the
highest number of dilated PWS blood vessels were imaged
by RCM scanning. The PWS blood vessels showing dark
tubular or circular structures with white blood cell
movement was observed during live RCM video.
The average PWS blood vessel depth was determined by
the location where the RCM images showing the highest
density of blood vessels. The average blood vessel density
was calculated by counting blood vessel numbers from 6 to
8 images in a 0.5 mm × 0.5 mm area from 2 to 3 layers
above and below 100 µm within the upper papillary
dermis. PWS blood vessels at that depth were used for
subsequent analysis of blood vessel diameters and
relative blood flow. The average blood vessel diameters
were analyzed on RCM images using ImageJ (2017
edition, Java‐based freeware; National Institutes of
Health, Bethesda, MD) software.
PWS blood flow was determined based on the calcula-
tion of peaks of luminous intensity of blood cells in the
vessels with the following modifications [22]. A blood
vessel perfusion value can be represented by the peak
pixel luminous intensity of blood cells. Changes in
frequency of the blood cells peak pixel intensity per image
composed in the RCM video could be used to reflect the
relative velocity of vessel perfusion; these arbitrary units
were calculated and subsequently applied as indexes for
relative blood flow in PWS blood vessels.
Clinical Outcome Evaluation
Digitalized high‐resolution photographs were taken at
baseline, immediately after each treatment and 2 months
after the final laser treatment. Clinical evaluations after
laser treatments were performed by two independent
dermatologists not involved in the study. The primary
efficacy measure, namely PWS clearance in response to
laser treatment, was scored into four categories: 4, complete
response (90–100% clearance); 3, response (60–89% clear-
ance); 2, improvement (20–59% clearance); and 1, ineffective
(<20% clearance). The effective rate was the sum of the
complete response, response, and improvement rates.
Statistical Analysis
The data was analyzed with the SPSS 22.0
software (IBM Inc, Armonk, NY). t Test and χ2 test were
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used to analyze the data for statistical analysis. P < 0.05
were considered statistically significant.
RESULTS
Three out of 33 subjects with facial PWS showed a
complete response, 12 showed manifested responses
(Fig. 1A and B), 13 showed improvements, and 5 showed
an ineffective response (Fig. 2A and B). The overall effective
rate was 84.85% (Table 1). Blood vessels in facial PWS that
were laser‐resistant showed a significantly higher blood
flow (1.35 ± 0.26 U vs. 0.89 ± 0.22 U, P < 0.001), larger blood
vessel diameters (109.60 ± 18.24 µm vs. 84.36 ± 24.04 µm, P
= 0.033), and were located deeper in the skin (106.01 ± 13.87
µm vs. 87.82 ± 12.57 µm, P < 0.001) when compared with
laser‐responsive PWS on the face (Fig. 3). Laser‐responsive
PWS on the face showed significantly lower relative blood
flow (0.57 ± 0.21 U vs. 0.89 ± 0.22 U, P < 0.001), less blood
vessel densities (8.25 ± 2.19/mm2 vs. 16.61 ± 4.44/mm2, P <
0.001), and smaller blood vessel diameters (49.04 ± 19.41 µm
vs. 84.36 ± 14.04 µm, P < 0.001) as well as an increase in
blood vessel depth (107.57 ± 12.38 µm vs. 87.82 ± 12.57 µm, P
< 0.001) after treatment when compared with baseline (Fig.
3). Laser‐resistant facial PWS did not show any statistically
significant differences in those morphological features of
blood vessels after treatment when compared with baseline
(Fig. 3).
In the extremity PWS group, no subject showed a
complete response, two showed manifested responses
(Fig. 4A and B), three exhibited improvements, and four
Fig. 1. A representative image of a male child (age 15) with laser‐
responsive port wine stain (PWS) on his right side of face and neck
before (A) and after (B) multiplex 585/1,064 nm laser treatment. The
reflectance confocal microscopy (RCM) images were taken from the
same lesional area before (C) and after (D) treatment. (E) and (F) are
higher magnifications from the boxed blood vessels in (C) and (D),
respectively. The PWS blood cells were indicated by yellow arrows.
The depths of imaging planes were 75 (before) and 100 µm (after
treatment). The diameters of the highlighted blood vessels were 223
(before) and 160 µm (after treatment). To be noted that the PWS
blood cells formed clusters in (E). Scale bar = 100 µm.
Fig. 2. A representative image of a young man (age 13) with laser‐
resistant port wine stain (PWS) on his right side of face before (A)
and after (B) multiplex 585/1,064 nm laser treatment. The
reflectance confocal microscopy (RCM) images were taken from the
same lesional area before (C) and after (D) treatment. (E) and (F) are
higher magnifications from the boxed blood vessels in (C) and (D),
respectively. The PWS blood cells were indicated by yellow arrows.
The depths of imaging planes were 100 (before) and 130 µm (after
treatment). The diameters of the highlighted blood vessels were 236
(before) and 205 µm (after treatment). Scale bar = 100 µm.
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showed an ineffective response (Fig. 5A and B). The
overall effective rate was 55.6%, which was statistically
significantly lower than that observed for facial PWS (P
< 0.01) (Table 1). Blood vessels in the laser‐resistant
extremity PWS showed a statistically significant higher
relative blood flow (1.33 ± 0.29 U vs. 0.97 ± 0.14 U, P =
0.042) when compared with laser‐responsive extremity
PWS (Fig. 6). The laser‐responsive extremity PWS blood
vessels showed statistically significant lower relative
blood flow (0.97 ± 0.14 U vs. 0.74 ± 0.16 U, P = 0.041)
and higher blood vessel densities (15.02 ± 1.58/mm2 vs.
10.01 ± 1.00/mm2, P < 0.001) after treatment when
compared with baseline (Fig. 6). Laser‐responsive
extremity PWS blood vessels also showed smaller blood
vessel diameters (108.50 ± 17.69 µm vs. 121.50 ± 23.81
µm, P = 0.291) and deeper blood vessel depths (109.50 ±
18.91 µm vs. 107.50 ± 11.90 µm, P = 0.823), which were
not statistically significant, after treatment when
compared with baseline (Fig. 6), probably due to the
limited sample size in this group. Laser‐resistant
extremity PWS did not show any statistically signifi-
cant changes in those blood vessels features after
treatment when compared with baseline (Fig. 6).
Moreover, PWS blood vessels showed statistically sig-
nificant larger diameters and depth in extremity lesions
when compared with facial lesions (Table 2). There were no
statistically significant differences in relative blood flow and
blood vessel densities between these two groups (Table 2).
TABLE 1. Comparison of Treatment Efficacies Among Patients in Two Groups
PWS group Complete response Response Improved Ineffective Overall response rate (%)
The facial PWS 3 12 13 5 84.85%
(n = 33) 9.09% 36.36% 39.39% 15.15%
The extremity PWS 0 2 3 4 55.55%*
(n = 9) 0%* 22.22% 33.33% 44.44%*
PWS, port wine stain.
*P < 0.001 in the facial PWS group vs. the extremity PWS group.
Fig. 3. xQuantitative analysis of relative blood flow (A), average blood vessel density (B),
diameter (C), and depth (D) in facial port wine stain (PWS) lesions before and after multiplex
585/1,064 nm laser treatment.
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DISCUSSION
The PDL produces reasonably good clinical results in
patients due to its ability to destroy superficial PWS blood
vessels (<300 µm below skin surface) [11–17]. Currently,
the vast majority of PWS patients receive a large number
(>20) of treatments to achieve reasonably good clearance
[18–20]. However, complete clearance occurs in <10% of
patients treated [18–20]. PDLs cannot achieve the critical
core temperature necessary to irreversibly destroy blood
vessels seated at deeper locations (>300 µm). Further-
more, epidermal melanin, residing over the abnormal
plexus of blood vessels, has relatively strong optical
absorption at the 585–595 nm treatment wavelengths.
Therefore, a large fraction of light intended to reach and
destroy the targeted PWS blood vessels is absorbed by
melanin, which prevents treatment of individuals with
moderate‐heavy pigmentation. In this study, the multi-
plex 585/1,064 nm laser was used to increase the optical
penetration depth to reach deeper blood vessels as well as
reduce light absorption by epidermal melanin. However,
44.4% of extremity PWS and 15.2% of facial PWS were
resistant to laser treatment, suggesting that these blood
vessels need tailored laser treatment protocols based on
their morphological features. For example, a higher laser
dosage can be considered for those laser‐resistant facial
PWS lesions with larger diameters of blood vessels.
There are many factors contributing to laser‐resistant
PWS, including lesion thickness, anatomical location,
size, and patient age [23]. The morphological aspects of
PWS blood vessels, namely depth (>400 µm), diameter
(<20 µm), and wall thickness are among the factors that
significantly impact treatment outcomes [24]. In the
current study, we quantitatively evaluated the morpholo-
gical features of PWS blood vessels in vivo by RCM. We
found that PWS blood vessel flow, diameter, and depth,
but not density, are the key factors contributing to the
laser‐resistance. In our study, we showed that the average
diameter of laser‐responsive facial PWS blood vessels
decreased from 84.36 to 49.04 µm after laser treatment,
suggesting that the remaining PWS blood vessels (dia-
meters < 49.04 µm) were more resistant to laser
treatment. Furthermore, we found that many PWS blood
vessels with larger diameters were also resistant to laser
treatments (Figs. 3 and 6), suggesting that molecular
phenotypes rather than morphological features are possi-
bly underlying the laser‐resistant mechanisms for those
blood vessels. We recently characterized a spectrum of
pathological and molecular phenotypes of PWS blood
vessels (i) the alterations of entire physiological milieu of
human skin, including ECs, smooth muscle cells and
extracellular matrix, in infantile PWS [25]; (ii) the
activation of the mitogen‐activated protein kinases,
PKCα, and phosphoinositide 3‐kinase in PWS blood
vessels [26,27]; (iii) upregulation of membrane trafficking
and exocytosis of PWS ECs [28]; and (iv) expression of
surface markers of EphB1/EphrinB2/CD133/CD166 on
PWS ECs [1]. These are the first steps toward uncovering
the molecular pathogenesis of PWS, which are likely
associated with laser‐resistant PWS phenotypes.
Recently, PDL in combination with anti‐angiogenic
agents has been evaluated for treatment for laser‐
resistant lesions and PWS recurrence. Molecularly,
laser‐induced local hypoxia leads to upregulation of
hypoxia‐inducible factor 1α and vascular endothelial
growth factor [29–31], causing activation of angiogenesis
pathways including phosphorylation of the mammalian
target of rapamycin and p70S6 kinase. As a result, more
angiogenic genes are transcribed and translated, leading
to reformation, and reperfusion of blood vessels. We
attempted to block this pathway using angiogenic in-
hibitors, such as rapamycin and axitinib [32–35], post‐
PDL treatment. In rodent skin, both topical rapamycin
and axitinib showed effective inhibition of the early stages
of angiogenesis induced by PDL, but blockage of the late
Fig. 4. A representative image of a female child (age 3) with
laser‐responsive port wine stain (PWS) on her left leg before (A)
and after (B) multiplex 585/1,064 nm laser treatment. The
reflectance confocal microscopy (RCM) images were taken from
the same lesional area before (C) and after (D) treatment. (E) and
(F) are higher magnifications from the boxed blood vessels in (C)
and (D), respectively. The PWS blood cells are indicated by yellow
arrows. The depths of imaging planes were 95 (before) and 110
µm (after treatment). The diameters of the highlighted blood
vessels were 172 (before) and 117 µm (after treatment). Scale bar
= 100 µm.
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stages of angiogenesis was ineffective [34,35]. These
results may explain why rapamycin improves PWS lesion
blanching in a limited subpopulation (~10%) of patients
[36,37]. However, there are still many gaps that need to be
filled before this approach can be successfully translated
to patients.
RCM is a non‐invasive optical imaging system that
enables visualization of cytomorphological features of skin
over time [21,38]. Facial lesions, such as PWS, are general
challenges for biopsies due to the cosmetically sensitive
nature of the area. RCM offers unique advantages for
recording the dynamics of the PWS microcirculation
including blood vessel density, size, location, and flow.
However, one major limitation of RCM is imaging depth.
The RCM device (VivaScope) employed in this study uses
830 nm light, which can penetrate to a maximal depth of
250–300 µm in the human skin. We found that imaging
quality significantly decreased when the penetration depth
was deeper than 150 µm during measurements. Therefore,
the maximal scanning depth of RCM used in this study
was about 150 µm to ensure that blood vessel structures
could be visualized and captured with sufficient resolution.
We were aware that we only captured a small fraction of
PWS blood vessels, which were located in the upper
papillary dermis. A large fraction of PWS blood vessels in
the reticular dermis were not imaged due to technical
limitations. Therefore, the data in the current study cannot
be considered to present the totality of PWS blood vessels
in the skin. Another limitation of this study is that it is
very challenging to image the same blood vessels before
and after treatment using RCM. Furthermore, PWS
lesions show blood vessel progressive dilations and soft
tissue hypotrophy during aging, which become more
resistant to laser treatment. In the current study, we were
unable to differentiate and compare the morphological
features of laser treatment‐resistant vasculatures in older
patients from young ones due to the limited sample sizes.
We will attempt to increase sample sizes and address this
issue in the future study.
Another limitation of this study is the semi‐quantifica-
tion approach for blood flow imaging using RCM. Altintas
et al. [39,40] pioneered methods to measure the quanti-
tative blood cell flow using RCM. Subsequently, Cinotti
et al. [22] compared three methods to calculate the blood
cells from RCM images: manual count, the number of
peak luminous intensity of blood vessel areas, and the
average intensity of the blood vessel areas. They found
that evaluation of the intensity peaks had good intra‐
capillary reproducibility and was the most reliable
approach. In the current study, we compared the changes
in frequency of intensity peaks of PWS blood vessel areas
from RCM videos over time, which revealed an index of
the speed of movements of red blood cells overall.
However, we do not know if each peak corresponds to a
single blood cell (Fig. 1F) or to a cluster of cells (Fig. 1E).
Further studies should be performed using real‐time
interpretation of RCM videos by software programs as
well as incorporation of the average intensity of blood
vessel areas, which may comprehensively present the
index of red blood cell numbers.
Other non‐invasive imaging systems that have been
used or currently under development for evaluation of
dermal vasculatures include laser Doppler flowmeter,
laser Doppler imaging, dermoscopy, cross‐polarized dif-
fuse reflection color imaging system, and optical coher-
ence tomography [39–48]. The main feature of RCM is
that it can directly reveal the dermal structure in a simple
and fast way, which makes it be a promising bedside tool
for prognostic evaluation. A dermatopathologist with a
special training of recognizing featured skin structures
under RCM will be required to operate RCM. RCM in
general only detect a small size of lesions (4 mm2) at one
time in just a few minutes, but not the entire PWS lesion.
One big limitation of RCM in the evaluation of vascular
Fig. 5. A representative image of a female child (age 4) with
laser‐resistant port wine stain (PWS) on her left leg before (A)
and after (B) multiplex 585/1,064 nm laser treatment. The
reflectance confocal microscopy (RCM) images were taken from
the same lesional area before (C) and after (D) treatment. (E) and
(F) are higher magnifications from the boxed blood vessels in (C)
and (D), respectively. The PWS blood cells were indicated by
yellow arrows. The depths of imaging planes were 115 (before)
and 110 µm (after treatment), respectively. The diameters of the
highlighted blood vessels were 248 (before) and 227 µm (after
treatment). Scale bar = 100 µm.
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malformations is the depth of blood vessels, which can be
overcomed by the Doppler ultrasound. However, it is also
challenging to evaluate the blood flow of small blood
vessels in some patients using the Doppler ultrasound
based on our experience. It will be worthy of investigating
the potential applications in a combination of RCM and
Doppler ultrasound in our future research. Furthermore,
the current data are only based 585/1,064 dual wave-
length‐resistant PWS lesions. We are aware that a single
wavelength laser treatment (such as 585 or 755 nm)
resistant PWS blood vessels may have different morpho-
logical features, therefore can affect our conclusions.
In conclusion, we quantitatively characterized the
general morphological features of laser‐resistant PWS
blood vessels, for example, blood flow, density, diameter,
and depth, using in vivo RCM in this study. Our results
have shown that laser‐resistant facial PWS blood vessels
had significantly higher blood flow, larger diameters, and
were located deeper in the skin when compared with
responsive PWS on the face. Our data also suggested that
RCM can be a valuable tool for a prognostic evaluation on
laser‐resistant lesions before treatment, thereby provid-
ing guidance for tailored laser treatment protocols, which
may improve the therapeutic outcome.
Fig. 6. Quantitative analysis of relative blood flow (A), average blood vessel density (B), diameter (C),
and depth (D) in extremity port wine stain (PWS) lesions before and after multiplex 585/1,064 nm laser
treatment.







diameter (µm) Blood vessel depth (µm)
Facial PWS (n = 33) 0.96 ± 0.28 16.67 ± 4.40 88.18 ± 27.77 90.58 ± 14.18
Extremity PWS (n = 9) 1.13 ± 0.28 15.44 ± 2.88 107.89 ± 23.42 101.11 ± 11.71
P value 0.115 0.437 0.038 0.047
PWS, port wine stain.
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